Viewing StudyNCT00560963



Ignite Creation Date: 2024-05-05 @ 6:54 PM
Last Modification Date: 2024-10-26 @ 9:38 AM
Study NCT ID: NCT00560963
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2007-11-19

Brief Title: Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus RAD001 and Gemcitabine
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Advanced or Metastatic Pancreatic Adenocarcinoma
Keywords:
Name View
everolimus View
Advanced or metastatic pancreas carcinoma View
gemcitabine View